Omicron detected in California, first case in the US, officials say

A traveler who returned to California from South Africa has become the first person in the United States identified to have the omicron variant of COVID-19, officials…

Read more

Omicron: What are the variant’s symptoms?

In just a matter of weeks, cases of the omicron COVID-19 variant have been detected in countries around the world – including the U.S. – forcing health…

Read more

More American adults living alone, Census Bureau reports

More American adults are living alone, according to newly released estimates from the U.S. Census Bureau’s annual America’s Families and Living Arrangement table package.  In a news…

Read more

Fauci says COVID-19 diverted resources from fight against AIDS

Dr. Anthony Fauci, the top U.S. infectious disease expert, said Tuesday the COVID-19 pandemic has diverted scientific and financial resources from the fight against AIDS, seriously impeding…

Read more

Travel amidst omicron: WHO says people aged 60 and older should delay travel to certain areas

In guidance released on international travel in relation to the COVID-19 omicron variant, the World Health Organization (WHO) wrote Tuesday that people ages 60 and older should…

Read more

FDA panel endorses first COVID-19 pill

A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first…

Read more

Covid: No need to cancel Christmas party plans – Javid

Take lateral flow test before socialising, health secretary suggests at start of two-month booster push. Click More

Read more

FDA approves ‘glowing tumor’ drug to help surgeons identify ovarian cancer cells

Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration…

Read more

Merck COVID-19 pill: FDA panel weighs safety, effectiveness

Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients…

Read more

University of Oxford on omicron: No proof COVID-19 vaccines won’t prevent against severe disease

The University of Oxford said Tuesday there was no evidence that current COVID-19 vaccines would not continue to protect against severe disease from the omicron variant.  “Despite the…

Read more